WHO to study three possible COVID-19 treatments

WHO mass-testing three potential COVID-19 treatments

GENEVA, Switzerland (AFP) - The World Health Organization (WHO) yesterday announced major international trials of three drugs to find out whether they improve the condition of hospitalised COVID-19 patients.Artesunate, imatinib and infliximab will be tested on thousands of volunteer patients in more than 600 hospitals in 52 countries."Finding more effective and accessible therapeutics for COVID-19 patients remains a critical need," said WHO Dire…

WHO-led trial to study three anti-inflammatory drugs for COVID-19 patients

ZURICH (Reuters) -The World Health Organization (WHO) said on Wednesday a clinical trial in 52 countries would study three anti-inflammatory drugs as potential treatments for COVID-19 patients.“These therapies – artesunate, imatinib and infliximab – were selected by an independent expert panel for their potential in reducing the risk of death in hospitalised COVID-19 patients,” it said in a statement on the Solidarity PLUS trial.Artesunate is al…

WHO to trial malaria, arthritis drugs as COVID treatments

Three drugs will be added to the UN agency’s global trial to test their efficacy in patients hospitalised with COVID-19.

WHO to test three existing drugs for use with COVID

The World Health Organization said Wednesday it will soon begin testing three drugs currently used for other diseases to see if they might help patients suffering from the coronavirus.

The WHO is testing three drugs in its search for potential COVID-19 treatments

A malaria drug, a cancer drug and a drug used for people with diseases of the immune system are being tested for use in COVID-19 patients, the WHO says.

Clinical trial in more than 50 countries to examine THREE possible treatments for COVID

A trio of anti-inflammatory drugs are being tested for use in virus patients.